A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: evaluation of efficacy, safety, and patient-reported outcomes
Kimura, Kosei, Iwamoto, Mitsuhiko, Tanaka, Satoru, Yamamoto, Daigo, Yoshidome, Katsuhide, Ogura, Hiroyuki, Terasawa, Risa, Matsunami, Nobuki, Takahashi, Yuko, Nitta, Toshikatsu, Morimoto, Takashi, Fujioka, Hiroya, Kawaguchi, Kanako, Uchiyama, Kazuhisa
Published in Cancer chemotherapy and pharmacology (01.05.2018)
Published in Cancer chemotherapy and pharmacology (01.05.2018)
Get full text
Journal Article
A phase II, multicenter, single-arm trial of eribulin as first or second line chemotherapy for HER2-negative advanced or metastatic breast cancer: Evaluation of efficacy, safety, and patient-reported outcomes
Iwamoto, Mitsuhiko, Kimura, Kosei, Tanaka, Satoru, Yamamoto, Daigo, Yoshidome, Katsuhide, Ogura, Hiroyuki, Terasawa, Risa, Matsunami, Nobuki, Takahashi, Yuko, Nitta, Toshikatsu, Morimoto, Takashi, Fujioka, Hiroya, Kawaguchi, Kanako, Uchiyama, Kazuhisa
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
A Case of Recurrent Breast Cancer with Delayed Wound Healing Induced by Bevacizumab
Terasawa, Risa, Hirata, Aoko, Aoki, Chinatsu, Kimura, Kosei, Morita, Shinsho, Hayashi, Michihiro
Published in Gan to kagaku ryoho (01.03.2024)
Get more information
Published in Gan to kagaku ryoho (01.03.2024)
Journal Article
A Case of Severe Drug-Induced Lung Injury during Preoperative Chemotherapy for Breast Cancer in the Early Stages of the COVID-19 Epidemic
Hirata, Aoko, Terasawa, Risa, Takashima, Yuko, Morita, Shinso, Kimura, Kousei, Iwamoto, Mitsuhiko, Hayashi, Michihiro
Published in Gan to kagaku ryoho (01.12.2023)
Get more information
Published in Gan to kagaku ryoho (01.12.2023)
Journal Article
Olaparib Could Be Re-Administered after Chemotherapy
Terasawa, Risa, Takashima, Yuko, Hirata, Aoko, Kimura, Kousei, Morita, Shinsho, Hayashi, Michihiro
Published in Gan to kagaku ryoho (01.04.2023)
Get more information
Published in Gan to kagaku ryoho (01.04.2023)
Journal Article
A Case of Squamous Cell Carcinoma of the Breast
Terasawa, Risa, Iwamoto, Mitsuhiko, Tanaka, Satoru, Kimura, Kosei, Takahashi, Yuko, Fujioka, Hiroya, Sato, Nayuko, Kawaguchi, Kanako, Ikari, Ayana, Maezawa, Saki, Tominaga, Tomo, Matsuda, Junna, Umezaki, Nodoka, Uchiyama, Kazuhisa
Published in Gan to kagaku ryoho (01.06.2016)
Get more information
Published in Gan to kagaku ryoho (01.06.2016)
Journal Article
Clinical features and outcomes of reversible posterior encephalopathy syndrome following bevacizumab treatment
Iwamoto, Mitsuhiko, Inoue, Shiori, Kawaguchi, Kanako, Terasawa, Risa, Fujioka, Hiroya, Kimura, Kosei, Uchiyama, Kazuhisa
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Eribulin improved overall survival in patients with HER-2 negative metastatic breast cancer: Comparison to bevacizumab plus paclitaxel
Iwamoto, Mitsuhiko, Umezaki, Nodoka, Matsuda, Juuna, Kawaguchi, Kanako, Terasawa, Risa, Sato, Nayuko, Fujioka, Hiroya, Kimura, Kosei, Tanaka, Satoru, Uchiyama, Kazuhisa
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer
Tanaka, Satoru, Matsunami, Nobuki, Morishima, Hirotaka, Oda, Naofumi, Takashima, Tsutomu, Noda, Satoru, Kashiwagi, Shinichiro, Tauchi, Yukie, Asano, Yuka, Kimura, Kosei, Fujioka, Hiroya, Terasawa, Risa, Kawaguchi, Kanako, Ikari, Ayana, Morimoto, Takashi, Michishita, Shintaro, Kobayashi, Toshihiro, Sakane, Junna, Nitta, Toshikatsu, Sato, Nayuko, Hokimoto, Norihiro, Nishida, Yukihiro, Iwamoto, Mitsuhiko
Published in Cancer chemotherapy and pharmacology (01.06.2019)
Published in Cancer chemotherapy and pharmacology (01.06.2019)
Get full text
Journal Article
A Phase II Study of Adjuvant Chemotherapy of Tegafur-Uracil for Patients with Breast Cancer with HER2-negative Pathologic Residual Invasive Disease After Neoadjuvant Chemotherapy
Tanaka, Satoru, Iwamoto, Mitsuhiko, Kimura, Kosei, Takahashi, Yuko, Fujioka, Hiyoya, Sato, Nayuko, Terasawa, Risa, Kawaguchi, Kanako, Ikari, Ayana, Tominaga, Tomo, Maezawa, Saki, Umezaki, Nodoka, Matsuda, Junna, Uchiyama, Kazuhisa
Published in Anticancer research (01.12.2016)
Published in Anticancer research (01.12.2016)
Get full text
Journal Article
Phase II study of eribulin mesylate as first- or second-line therapy for metastatic HER2-negative breast cancer
Iwamoto, Mitsuhiko, Sato, Nayuko, Terasawa, Risa, Fujioka, Hiroya, Takahashi, Yuko, Kimura, Kosei, Tanaka, Satoru, Uchiyama, Kazuhisa
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Safety of nanoparticle albumin-bound paclitaxel administered to breast cancer patients with clinical contraindications to paclitaxel or docetaxel: Four case reports
KIMURA, KOSEI, TANAKA, SATORU, IWAMOTO, MITSUHIKO, FUJIOKA, HIROYA, TAKAHASHI, YUKO, SATO, NAYUKO, TERASAWA, RISA, TOMINAGA, TOMO, IKARI, AYANA, UCHIYAMA, KAZUHISA
Published in Oncology letters (01.10.2013)
Published in Oncology letters (01.10.2013)
Get full text
Journal Article
Outpatient management without initial assessment for febrile patients undergoing adjuvant chemotherapy for breast cancer
Kimura, Kosei, Tanaka, Satoru, Iwamoto, Mitsuhiko, Fujioka, Hiroya, Sato, Nayuko, Terasawa, Risa, Kawaguchi, Kanako, Matsuda, Junna, Umezaki, Nodoka, Uchiyama, Kazuhisa
Published in Molecular and clinical oncology (01.10.2016)
Published in Molecular and clinical oncology (01.10.2016)
Get full text
Journal Article